Are SoulCycle stationary bikes likely to continue their fast track to world domination? David Hirschy explores the fitness industry's new wunderkind.
CRISPR: The Promise and Peril of Modern Biotech Investments by Gabriel Ferrante C'17
New discoveries and fast paced change make the modern day an exhilarating time to be in the sciences, but for the investor, they offer challenges as well as the possibility of high reward. Gabriel Ferrante investigates Editas, a recently public biotech firm, and its chances of creating value for shareholders.